Merck Millipore
Multi-disciplinary scientific expertise and a broad portfolio of technologies, tools and services for bioscience research and biopharmaceutical manufacturing
Millipore was incorporated in 1954 by Jack Bush as a membrane company. In July 2010, Millipore was acquired by Merck and is now operating as “Merck Millipore”.
Dr. Bernd Reckmann (President Merck Millipore)
290 Concord Road
Billerica, MA 01821
USA
Phone: 978-715-4321
Related patents
Related news
- Merck KGaA, Darmstadt, Germany Completes Millipore Acquisition and Launches New EMD Millipore Division (Merck Millipore Division outside U.S. and Canada)
- Millipore Expands Chromatography Offering With Launch of ProRes(TM)-S Media
- Millipore Announces Date and Time of First Quarter 2010 Earnings Release and Webcast
- Merck KGaA and Millipore Announce Transaction
- Millipore Corporation Confirms It is Evaluating Strategic Alternatives
- Millipore Delivers Outstanding 2009 Financial Results
- Millipore Announces Date and Time of Fourth Quarter and Fiscal 2009 Earnings Release and Webcast
- Millipore Strengthens Position in Virus Safety with Launch of Innovative Product Line
- Dr. Robert Langer Joins Millipore's Board of Directors
- Millipore Acquires Remaining Ownership of its Joint-Venture in India
- Millipore Launches First Automated Cell Counter that Fits Into the Palm of the Hand
- Millipore Reports Third Quarter 2009 Financial Results
- Millipore Announces Date and Time of Third Quarter 2009 Earnings Release and Webcast
- Millipore Corporation Awards Flow Cytometer to Advance Cell Biology Research at Renowned Research Hospital
- Millipore and Roka Bioscience to Develop Real-Time Molecular Tests for Biopharmaceutical Applications
- Millipore to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2009
- Millipore Corporation Appoints New Vice President of Life Science Business Uni
- Millipore Reports Second Quarter 2009 Financial Results
- Millipore Sues W.L. Gore & Associates for Patent Infringement
- Millipore Reports Strong First Quarter Financial Results and Raises Outlook for 2009
- Millipore to Webcast Annual Shareholder Meeting
- Millipore Unveils Industry's Most Integrated Single-Use Manufacturing Solutions at INTERPHEX 2009
- Millipore Announces Technology Acquisition to Strengthen Drug Discovery Product Offering
- Millipore Expands Cell Biology Offering With Acquisition of Guava Technologies
- Millipore Corporation Signs License Agreement with Astellas
- Millipore and Applikon Biotechnology Form Collaboration to Expand Offerings in Fast-Growing Disposable Manufacturing Market
- Millipore to Present at Upcoming Investor Conferences
- Millipore Corporation Announces Appointment of Karen Marinella Hall as Director, Corporate Communications
- Millipore Corporation's Re-Branding Underscores Expanded Capabilities and Partnership with Customers
- Millipore and Novo Nordisk Expand Agreement to Supply Biopharmaceutical Market with Recombinant Human Insulin
- Millipore Announces Date and Time of Second Quarter Earnings Release and Webcast
- Millipore to Webcast Presentation at Bank of America 2007 Health Care Conference
- Millipore and Gen-Probe Expand Collaboration
- Millipore to Webcast Annual Shareholder Meeting
- Millipore Reports First Quarter Financial Results
- Millipore Announces New Chief Financial Officer
- Millipore Showcases Innovative Products at INTERPHEX(R) 2007 Conference
- Millipore Announces Date and Time of First Quarter Earnings Release and Webcast
- Millipore Becomes First Company to Embed RFID Technology in Filtration Products Used for Biopharmaceutical Manufacturing
- Millipore to Webcast Presentation at 10th Annual Lehman Brothers Global Healthcare Conference
- Millipore's Laboratory Water Business Unit Driving Growth with Innovative Solutions
- Millipore to Webcast Presentation at Merrill Lynch 2007 Global Pharmaceutical, Biotechnology & Medical Device Conference
- Millipore Announces Date and Time of Fourth Quarter Earnings Release and Webcast
- Millipore Reports Third Quarter Financial Results
- Millipore to Webcast Presentation at UBS Global Life Sciences Conference
- Millipore Reports Second Quarter Financial Results
- Millipore Completes Acquisition of Serologicals
- Millipore Announces Date and Time of Second Quarter Earnings Release and Conference Call; Earnings Release and Conference Call to Be Held on Wednesday, July 26, 2006
- Serologicals Shareholders Approve Millipore's Buyout
- Millipore Prices $550 Million Senior Convertible Notes
- Millipore to Offer $550 Million Convertible Senior Notes
- Millipore Chosen to Present at UBS Securities' Best of Americas Conference
- Millipore Corporation to Acquire Serologicals
- Millipore Strengthens Disposable Bioprocessing Solutions with Acquisition of Newport Bio Systems; Acquisition Will Enable Increased Speed and Flexibility in Delivering Integrated Disposable Solutions
- Millipore Announces Investments to Support Growth in Emerging International Markets; Company Adds New Management, Expands International Offices, And Builds New Manufacturing Capabilities
- Millipore to Present at Lehman Brothers Global Healthcare Conference
- Millipore to Present at Citigroup's Global Healthcare Conference
- Millipore Recognized for Leadership in Corporate and Social Responsibility; Company Named to KLD's Domini 400 Social Index
- Millipore Upgraded by Moody's Investor Service
- Millipore to Present at Merrill Lynch Investor Conference
- Millipore Reports Strong Fourth Quarter and Full Year Revenue Growth; Improved Execution, Leadership in Fast Growing Markets ...